| Shukra Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524632 |
NSE Symbol : SHUKRAPHAR |
P/E(TTM) : 67.37 |
|
ISIN Demat : INE551C01044 |
Div & Yield% : 0.02 |
EPS(TTM) : 0.82 |
|
Book Value(₹) : 2.27 |
Market Cap(₹Cr) : 2,434.91 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 23.52 | 6.30 | 39.13 | 5.88 | 5.39 | 13.27 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 23.52 | 6.30 | 39.13 | 5.88 | 5.39 | 13.27 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.54 | 0.95 | 0.82 | 1.71 | 1.11 | 1.47 |
| Total Income | 24.06 | 7.25 | 39.95 | 7.59 | 6.50 | 14.74 |
| Total Expenditure | 2.32 | 5.62 | 12.00 | 6.30 | 4.07 | 5.95 |
| PBIDT | 21.75 | 1.63 | 27.95 | 1.29 | 2.43 | 8.78 |
| Interest | 0.43 | 0.26 | 0.28 | 0.29 | 0.27 | 0.27 |
| PBDT | 21.32 | 1.38 | 27.67 | 1.01 | 2.16 | 8.51 |
| Depreciation | 1.07 | 1.01 | 0.84 | 0.81 | 0.79 | 0.94 |
| Tax | 5.17 | 4.43 | 4.11 | 0.00 | 0.41 | 2.18 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.04 | -2.33 | 2.35 | -2.18 | -0.06 | 0.00 |
| Reported Profit After Tax | 15.03 | -1.73 | 20.36 | 2.38 | 1.03 | 5.39 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 15.03 | -1.73 | 20.36 | 2.38 | 1.03 | 5.39 |
| EPS (Unit Curr.) | 0.34 | -0.04 | 0.47 | 0.05 | 0.02 | 0.12 |
| EPS (Adj) (Unit Curr.) | 0.34 | -0.04 | 0.47 | 0.05 | 0.02 | 0.12 |
| Calculated EPS (Unit Curr.) | 0.34 | -0.04 | 0.47 | 0.05 | 0.02 | 0.12 |
| Calculated EPS (Adj) (Unit Curr.) | 0.34 | -0.04 | 0.47 | 0.05 | 0.02 | 0.12 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.37 | -0.16 | 1.86 | 0.22 | 0.09 | 0.49 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.37 | -0.16 | 1.86 | 0.22 | 0.09 | 0.49 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 43.79 | 43.79 | 43.79 | 43.79 | 43.79 | 43.79 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 22.02 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 92.47 | 25.87 | 71.43 | 21.94 | 45.08 | 66.16 |
| PBDTM(%) | 90.65 | 21.90 | 70.71 | 17.18 | 40.07 | 64.13 |
| PATM(%) | 63.90 | -27.46 | 52.03 | 40.48 | 19.11 | 40.62 |
